Researchers from Inocras, a bioinformatics-led company harnessing the power of whole-genome data and proprietary analytics to advance precision health, and the Broad Institute of MIT and Harvard will ...

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

BENGALURU: In a significant step towards strengthening Karnataka’s leadership in emerging technologies, the state cabinet has ...

The Karnataka Cabinet has approved the establishment of a Centre of Excellence for Artificial Intelligence in Biotechnology ...

Rosalind, a biological language model for target discovery and genomics. Currently only available for US corporate customers.

ESTABLISHING a national precision medicine strategy, anchored by a clearly defined coordinating body tops the priority list ...

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

Genomics, Inc. , a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell ...

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

Efforts to improve cancer imaging technologies are crucial for diagnosing and treating the disease effectively. This transition from experimental to clinical use requires bridging the gap between ...